{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:57:19Z","timestamp":1791424639477,"version":"4.3.3"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.jocn.2011.01.031","type":"journal-article","created":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T23:56:18Z","timestamp":1311810978000},"page":"1313-1317","source":"Crossref","is-referenced-by-count":151,"title":["Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse"],"prefix":"10.1016","volume":"18","author":[{"given":"H.H.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.Q.","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.Q.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.H.","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.G.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.Q.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2011.01.031_b0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/pgmj.2009.091389","article-title":"Neuromyelitis optica: an overview","volume":"86","author":"Nandhagopal","year":"2010","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jocn.2011.01.031_b0010","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2011.01.031_b0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-0404.2008.01002.x","article-title":"Neuromyelitis optica: a distinct demyelinating disease of the central nervous system","volume":"118","author":"Argyriou","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jocn.2011.01.031_b0020","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jocn.2009.09.014","article-title":"The past, present and future of imaging in multiple sclerosis","volume":"17","author":"Ramli","year":"2010","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2011.01.031_b0025","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2011.01.031_b0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jns.2009.08.045","article-title":"Neuromyelitis optica: effect of gender","volume":"5","author":"Wingerchuk","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2011.01.031_b0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00281-009-0186-z","article-title":"Th17 cells in autoimmune demyelinating disease","volume":"32","author":"Segal","year":"2010","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jocn.2011.01.031_b0040","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.25.022106.141557","article-title":"IL-17 family cytokines and the expanding diversity of effector T cell lineages","volume":"25","author":"Weaver","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jocn.2011.01.031_b0045","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.4049\/jimmunol.0900368","article-title":"Tc17 CD8 T cells: functional plasticity and subset diversity","volume":"183","author":"Yen","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jocn.2011.01.031_b0050","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.micinf.2009.04.003","article-title":"IL-17 and Th17 cells in human inflammatory diseases","volume":"11","author":"Miossec","year":"2009","journal-title":"Microbes Infect"},{"key":"10.1016\/j.jocn.2011.01.031_b0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","article-title":"Th17 cells in human disease","volume":"223","author":"Tesmer","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jocn.2011.01.031_b0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00281-009-0186-z","article-title":"Th17 cells in autoimmune demyelinating disease","volume":"32","author":"Segal","year":"2010","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jocn.2011.01.031_b0065","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","article-title":"IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis","volume":"177","author":"Komiyama","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jocn.2011.01.031_b0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/135245859900500206","article-title":"Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis","volume":"5","author":"Matusevicius","year":"1999","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2011.01.031_b0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-0404.2009.01158.x","article-title":"Effect of high-dose methylprednisolone treatment on Th17 cells in patients with multiple sclerosis in relapse","volume":"120","author":"Liu","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jocn.2011.01.031_b0080","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jocn.2011.01.031_b0085","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1084\/jem.20072404","article-title":"The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease","volume":"205","author":"Carlson","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jocn.2011.01.031_b0090","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1093\/brain\/awp289","article-title":"Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis","volume":"132","author":"Brucklacher-Waldert","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2011.01.031_b0095","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jocn.2011.01.031_b0100","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature07021","article-title":"IL-21 and TGF-beta are required for differentiation of human T(H)17 cells","volume":"454","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jocn.2011.01.031_b0105","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.4049\/jimmunol.0801814","article-title":"Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge","volume":"182","author":"Hamada","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jocn.2011.01.031_b0110","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/sj.icb.7100114","article-title":"Autoimmunity: IL-21: a new player in Th17-cell differentiation","volume":"85","author":"Deenick","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jocn.2011.01.031_b0115","doi-asserted-by":"crossref","first-page":"12099","DOI":"10.1073\/pnas.0705268104","article-title":"IL-6-dependent and independent pathways in the development of interleukin 17-producing T helper cells","volume":"104","author":"Kimura","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jocn.2011.01.031_b0120","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.4049\/jimmunol.0900036","article-title":"IL-23 drives pathogenic IL-17-producing CD8+ T cells","volume":"182","author":"Ciric","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jocn.2011.01.031_b0125","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2011.01.031_b0130","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2011.01.031_b0135","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jns.2010.02.026","article-title":"Characteristic linear lesions and longitudinally extensive spinal cord lesions in Chinese patients with neuromyelitis optica","volume":"293","author":"Lu","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2011.01.031_b0140","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.it.2004.01.007","article-title":"The CD4+Th1 model for multiple sclerosis: a crucial re-appraisal","volume":"25","author":"Lassmann","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jocn.2011.01.031_b0145","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/eji.200939412","article-title":"A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity","volume":"39","author":"Huber","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jocn.2011.01.031_b0150","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/WCO.0b013e3280be58d8","article-title":"Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis","volume":"20","author":"Wingerchuk","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jocn.2011.01.031_b0155","first-page":"167","article-title":"Opticospinal multiple sclerosis in Japanese","volume":"13","author":"Kira","year":"2008","journal-title":"Neurol Asia"},{"key":"10.1016\/j.jocn.2011.01.031_b0160","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.4049\/jimmunol.0803009","article-title":"IL-21: an executor of B cell fate","volume":"182","author":"Konforte","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jocn.2011.01.031_b0165","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1084\/jem.20091777","article-title":"IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism","volume":"207","author":"Zotos","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.jocn.2011.01.031_b0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.humimm.2008.10.021","article-title":"Interleukin-21 stimulates B-cell immunoglobulin E synthesis in human beings concomitantly with activation-induced cytidine deaminase expression and differentiation into plasma cells","volume":"70","author":"Kobayashi","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jocn.2011.01.031_b0175","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/00207450903428970","article-title":"Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients","volume":"120","author":"I\u00e7\u00f6z","year":"2010","journal-title":"Int J Neurosci"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758681100186X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758681100186X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T09:45:16Z","timestamp":1560419116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096758681100186X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S096758681100186X"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2011.01.031","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}